Wallaby Medical Holding, Inc. ("Wallaby") is a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke. Established in 2015, we currently have over 250 employees located in Laguna Hills, California and Shanghai, China.
We develop and produce some of the most reliable and technologically advanced products supported by proven clinical data. Our commercialized product portfolio includes the Avenir® Coil System, a technically differentiated neuro embolic coil system for treating intracranial aneurysms and other neurovascular abnormalities, the Esperance™ Aspiration Catheters for use in the revascularization of patients with acute ischemic stroke, and the Esperance™ Distal Access Catheter for general intravascular usage including neuro.
We market our products in over 30 countries and regions around the world, including the U.S., China, Europe and Japan. In addition, we have a full range of neurovascular interventional products currently under development.